Transcat Inc's Corporate Customers have recorded a rise in their cost of revenue by 20.89 % in the 2 quarter 2026 year on year, sequentially costs of revenue grew by 9.68 %. During the corresponding time, Transcat Inc recorded a revenue increase by 18.01 % year on year, sequentially revenue grew by 4.46 %. While revenue at the Transcat Inc's corporate clients recorded rose by 17.62 % year on year, sequentially revenue grew by 10.18 %.
Transcat Inc's Customers have recorded a rise in their cost of revenue by 20.89 % in the 2 quarter 2026 year on year, sequentially costs of revenue grew by 9.68 %, for the same period Transcat Inc recorded revenue increase by 18.01 % year on year, sequentially revenue grew by 4.46 %.
Transcat Inc's Comment on Sales, Marketing and Customers
The company serves approximately 27,000 customers through its Service and Distribution segments, with 20% to 25% of customers transacting through both segments. It has expanded its operations through acquisitions, including Essco Calibration Laboratory, LLC; Martin Calibration, LLC; Becnel Rental Tools, LLC; and SCM Metrology and Laboratories S. A. The Service segment provides calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and related services, supported by proprietary systems CalTrak® and C3®. The company operates 33 calibration service centers across the United States (including Puerto Rico), Canada, Ireland, and Costa Rica, and offers onsite services such as client-based laboratories and mobile calibration laboratories. All centers hold ISO/IEC 17025:2017 accreditation. Transcat Solutions delivers asset management services to the biopharmaceutical industry through six service tracks: calibration, maintenance and spare, reliability, computerized maintenance management systems (CMMS), quality and compliance, and validation, focusing on managing asset portfolios, reducing downtime, accelerating product delivery, and driving cost savings and improvements.
Transcat Inc’s Comment on Sales, Marketing and Customers
The company serves approximately 27,000 customers through its Service and Distribution segments, with 20% to 25% of customers transacting through both segments. It has expanded its operations through acquisitions, including Essco Calibration Laboratory, LLC; Martin Calibration, LLC; Becnel Rental Tools, LLC; and SCM Metrology and Laboratories S. A. The Service segment provides calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and related services, supported by proprietary systems CalTrak® and C3®. The company operates 33 calibration service centers across the United States (including Puerto Rico), Canada, Ireland, and Costa Rica, and offers onsite services such as client-based laboratories and mobile calibration laboratories. All centers hold ISO/IEC 17025:2017 accreditation. Transcat Solutions delivers asset management services to the biopharmaceutical industry through six service tracks: calibration, maintenance and spare, reliability, computerized maintenance management systems (CMMS), quality and compliance, and validation, focusing on managing asset portfolios, reducing downtime, accelerating product delivery, and driving cost savings and improvements.
Sources:
Transcat Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Transcat Inc’s corporate clients.
For your research, we’ve provided 9 tables on Transcat Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
64.59 %
11.31 %